[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Rx/Reimbursement Adult Incontinence in the Czech Republic

March 2024 | 18 pages | ID: RE9DD6E2F09EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In 2023, Rx/reimbursement adult incontinence recorded moderate volume growth, resulting from growing consumer awareness not only of incontinence, but also from health insurance companies and their reimbursement payments to consumers for the condition, depending on the level of incontinence. Incontinence products are considered medical products under Czech law and are subsidised by health insurance companies if prescribed by doctors. As a result, price plays an important role in demand in the Rx/...

Euromonitor International's Rx/Reimbursement adult incontinence in Czech Republic report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Rx/Reimbursement Adult Incontinence in the Czech Republic
Euromonitor International
March 2024

LIST OF CONTENTS AND TABLES

RX/REIMBURSEMENT ADULT INCONTINENCE IN THE CZECH REPUBLIC
KEY DATA FINDINGS

2023 DEVELOPMENTS

Moderate growth for Rx/reimbursement adult incontinence, with the category not helped by a change in the law
Consumer embarrassment remains an obstacle to growth
Essity continues to lead the pack with its trusted Tena brand
PROSPECTS AND OPPORTUNITIES
Rx/reimbursement adult incontinence sees growing sales as awareness increases
Expenditure reduction by health companies constrains category forecast period growth
Electronic reimbursement of medical equipment, including adult incontinence products, is expected during the forecast period
CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2023-2028
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2023-2028
TISSUE AND HYGIENE IN THE CZECH REPUBLIC
EXECUTIVE SUMMARY
Tissue and hygiene in 2023: The big picture

2023 KEY TRENDS

Competitive landscape
Retailing developments
What next for tissue and hygiene?
MARKET INDICATORS
Table 5 Birth Rates 2018-2023
Table 6 Infant Population 2018-2023
Table 7 Female Population by Age 2018-2023
Table 8 Total Population by Age 2018-2023
Table 9 Households 2018-2023
Table 10 Forecast Infant Population 2023-2028
Table 11 Forecast Female Population by Age 2023-2028
Table 12 Forecast Total Population by Age 2023-2028
Table 13 Forecast Households 2023-2028
MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2019-2023
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2020-2023
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2018-2023
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2018-2023
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2023
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2023-2028
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2023-2028
DISCLAIMER
SOURCES
Summary 1 Research Sources


More Publications